The estimated Net Worth of Paul Herendeen is at least $7.09 Million dollars as of 9 September 2022. Mr. Herendeen owns over 10,000 units of Bausch Health Companies Inc stock worth over $110,419 and over the last 10 years he sold BHC stock worth over $0. In addition, he makes $6,977,360 as Chief Financial Officer and Executive Vice President at Bausch Health Companies Inc.
Paul has made over 5 trades of the Bausch Health Companies Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 10,000 units of BHC stock worth $150,300 on 9 September 2022.
The largest trade he's ever made was exercising 49,324 units of Bausch Health Companies Inc stock on 8 March 2021 worth over $314,687. On average, Paul trades about 3,385 units every 63 days since 2014. As of 9 September 2022 he still owns at least 17,307 units of Bausch Health Companies Inc stock.
You can see the complete history of Mr. Herendeen stock trades at the bottom of the page.
Paul S. Herendeen is Chief Financial Officer, Executive Vice President of the company. Prior to joining Bausch Health, he served as Executive Vice President and CFO of Zoetis Inc. for two years. From 2005 to 2013 and from 1998 to 2001, Mr. Herendeen served as CFO at Warner Chilcott, a specialty pharmaceuticals company. He rejoined Warner Chilcott after four years as EVP and CFO of MedPointe Pharmaceuticals, a privately held healthcare company, where he served as CFO from 2001 until 2005. Prior to that, Mr. Herendeen spent nine years as a principal investor at both Dominion Income Management and Cornerstone Partners, where he worked on investments as well as mergers and acquisitions for the firms and their portfolio companies. He spent the early part of his career in banking and public accounting, having held various positions with the investment banking group of Oppenheimer & Company, the capital markets group of Continental Bank Corporation and as a senior auditor with Arthur Andersen & Company. Mr. Herendeen earned a Master of Business Administration from the University of Virginia’s Darden School of Business and holds a bachelor’s degree in Business Administration from Boston College.
As the Chief Financial Officer and Executive Vice President of Bausch Health Companies Inc, the total compensation of Paul Herendeen at Bausch Health Companies Inc is $6,977,360. There are 1 executives at Bausch Health Companies Inc getting paid more, with Joseph Papa having the highest compensation of $17,141,600.
Paul Herendeen is 64, he's been the Chief Financial Officer and Executive Vice President of Bausch Health Companies Inc since 2016. There are 7 older and 13 younger executives at Bausch Health Companies Inc. The oldest executive at Bausch Health Companies Inc is Richard De Schutter, 79, who is the Independent Director.
Paul's mailing address filed with the SEC is C/O ELANCO ANIMAL HEALTH INCORPORATED, 2500 INNOVATION WAY, GREENFIELD, IN, 46140.
Over the last 6 years, insiders at Bausch Health Companies Inc have traded over $2,786,244 worth of Bausch Health Companies Inc stock and bought 6,317,686 units worth $110,094,785 . The most active insiders traders include John Paulson, Argeris N Karabelas, and Brett Icahn. On average, Bausch Health Companies Inc executives and independent directors trade stock every 36 days with the average trade being worth of $824,564. The most recent stock trade was executed by Seana Carson on 5 September 2024, trading 13,370 units of BHC stock currently worth $83,028.
bausch health companies inc. (nyse/tsx: bhc) is a global company that develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. we are delivering on our commitments as we build an innovative company dedicated to advancing global health. our approximately 22,000 employees are united around our mission of improving people’s lives with our health care products, and we manufacture and market health care products directly or indirectly in approximately 100 countries.five pillars, or guiding principles, represent the foundation on which we are realizing our mission as an organization: people, quality health care outcomes, customer focus, innovation and efficiency. more information can be found at www.bauschhealth.com.###
Bausch Health Companies Inc executives and other stock owners filed with the SEC include: